세계의 근육통 치료 시장 보고서(2025년)

Treatment for muscle pain involves managing and easing discomfort and inflammation in muscles. This typically includes rest, applying heat or cold therapy, using over-the-counter pain relievers, and sometimes undergoing physical therapy or taking prescription medications for more severe cases. The goal of effective treatment is to reduce pain, facilitate healing, and restore normal muscle function.

Pharmacological approaches to treating muscle pain include analgesics, muscle relaxants, topical analgesics, and other medications. Analgesics are drugs specifically designed to alleviate pain without causing unconsciousness. Non-pharmacological treatments encompass physical therapy, massage therapy, acupuncture, heat and cold therapy, exercise, stretching, and other methods. These treatments target various types of pain, such as acute and chronic muscle pain resulting from overuse, injury, inflammation, neurological conditions, infections, and other causes. They are administered in various settings, including hospitals and clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The muscle pain treatment market research report is one of a series of new reports from The Business Research Company that provides muscle pain treatment market statistics, including muscle pain treatment industry global market size, regional shares, competitors with a muscle pain treatment market share, detailed muscle pain treatment market segments, market trends and opportunities, and any further data you may need to thrive in the muscle pain treatment industry. This muscle pain treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The muscle pain treatment market size has grown steadily in recent years. It will grow from $12.95 billion in 2024 to $13.59 billion in 2025 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to aging population with a higher incidence of chronic pain conditions, an increase in sports injuries due to higher participation rates, the prevalence of manual labor jobs leading to musculoskeletal disorders, sedentary lifestyles contributing to muscle stiffness and pain, and a lack of exercise causing muscle atrophy and pain.

The muscle pain treatment market size is expected to see strong growth in the next few years. It will grow to $16.66 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to increasing adoption of non-opioid and non-invasive pain management treatments, rising healthcare expenditures and demand for effective pain management solutions, regulatory approvals for new pain management therapies and devices, emphasis on preventive healthcare to mitigate chronic pain conditions, and growing demand for alternative therapies like acupuncture and chiropractic care. Major trends in the forecast period include telehealth and virtual consultations for pain management, the development of wearable pain relief devices and smart clothing, biopharmaceutical innovations in pain treatment, AI-driven personalized pain management solutions, and regenerative medicine techniques for tissue repair and pain reduction.

The forecast of 5.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of electromyography (EMG) devices and compounded pain creams sourced from Canada and Italy, thereby limiting non-opioid treatment options and elevating physical medicine costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The muscle pain treatment market is expected to grow due to the increasing prevalence of musculoskeletal disorders. Musculoskeletal disorders affect the muscles, bones, and joints, causing pain, stiffness, and limited movement. Factors contributing to rising cases include aging populations, sedentary lifestyles, and the increasing incidence of chronic conditions. Treatment aims to alleviate symptoms by reducing pain, improving mobility, preventing complications, and enhancing overall quality of life and function. According to a November 2023 study by The Lancet, an estimated 494 million people globally experienced musculoskeletal disorders in 2020, with projections suggesting a potential 115% increase by 2050. As a result, the muscle pain treatment market is expanding.

Leading companies in this market are innovating by developing products such as topical analgesics to improve effectiveness and user convenience. These medications are applied directly to the skin to relieve pain in targeted areas, commonly used for muscle aches, arthritis, and minor injuries. For example, in July 2024, Wellness Formulations LLC introduced Ralli Rapid Pain Relief, featuring menthol for pain relief along with advanced penetration enhancers and skin conditioners. Available in gel, spray, and roll-on formats, it offers quick and long-lasting relief from muscle aches, joint pain, arthritis, strains, and sprains, without leaving a greasy residue. This allows for easy application directly to affected areas, eliminating the need for rubbing or massaging.

In February 2022, Athletico Physical Therapy, a US-based provider of physical therapy and orthopedic rehabilitation services, completed the acquisition of Pivot Health Solutions for an undisclosed sum. This strategic move strengthens Athletico's position in the muscle pain treatment market by expanding its geographic reach and enhancing capabilities in physical therapy and occupational health. The acquisition also brings seasoned leadership to Athletico and reinforces its commitment to delivering high standards of patient care. Pivot Health Solutions, also based in the US, specializes in physical therapy, occupational health, and onsite corporate health services, focusing on treating muscle pain and other physical ailments.

Major companies operating in the muscle pain treatment market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Haleon Plc, Select Medical Holdings Corporation, Purdue Pharma, Endo Pharmaceuticals Inc., Concentra Inc., Athletico Physical Therapy, ATI Physical Therapy Inc., Physiotherapy Associates Inc, NovaCare Rehabilitation Inc, CORA Health Services Inc., Select Physical Therapy Holdings Inc., ProActive Physical Therapy

North America was the largest region in the muscle pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the muscle pain treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The muscle pain treatment market consists of revenues earned by entities by providing services such as chiropractic care, hydrotherapy, occupational therapy, transcutaneous electrical nerve stimulation (TENS), cognitive-behavioral therapy (CBT), and myofascial release therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The muscle pain treatment market also includes sales of acetaminophen, corticosteroids, and nonsteroidal anti-inflammatory drugs (NSAIDs). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Muscle Pain Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on muscle pain treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for muscle pain treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The muscle pain treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Pharmacological Treatment: Analgesics; Muscle Relaxants; Topical Analgesics; Other Pharmacological Treatments
• 2) By Non-Pharmacological Treatment: Physical Therapy; Massage Therapy; Acupuncture; Heat And Cold Therapy; Exercise And Stretching; Other Non-Pharmacological Treatments
• 3) By Type Of Pain: Acute Muscle Pain; Chronic Muscle Pain
• 4) By Cause Of Muscle Pain: Overuse And Strain; Injury Or Trauma; Inflammatory Conditions; Neurological Conditions; Infections; Other Cause Of Muscle Pain
• 5) By Application: Hospital; Clinic; Other Applications
• Subsegments:
• 1) By Analgesics: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Acetaminophen
• 2) By Muscle Relaxants: Centrally Acting Muscle Relaxants; Peripherally Acting Muscle Relaxants
• 3) By Topical Analgesics: Creams & Ointments; Gels & Sprays; Patches
• 4) By Other Pharmacological Treatments: Corticosteroids; Antidepressants; Anticonvulsants
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Sanofi SA; Bristol Myers Squibb Company; AstraZeneca PLC; Novartis International AG; GlaxoSmithKline plc (GSK); Eli Lilly and Company; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Baxter International Inc.; Haleon Plc; Select Medical Holdings Corporation; Purdue Pharma; Endo Pharmaceuticals Inc.; Concentra Inc.; Athletico Physical Therapy; ATI Physical Therapy Inc.; Physiotherapy Associates Inc; NovaCare Rehabilitation Inc; CORA Health Services Inc.; Select Physical Therapy Holdings Inc.; ProActive Physical Therapy
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Muscle Pain Treatment Market Characteristics

3. Muscle Pain Treatment Market Trends And Strategies

4. Muscle Pain Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Muscle Pain Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Muscle Pain Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Muscle Pain Treatment Market Growth Rate Analysis
• 5.4. Global Muscle Pain Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Muscle Pain Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Muscle Pain Treatment Total Addressable Market (TAM)

6. Muscle Pain Treatment Market Segmentation

• 6.1. Global Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Analgesics
• Muscle Relaxants
• Topical Analgesics
• Other Pharmacological Treatments
• 6.2. Global Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Therapy
• Massage Therapy
• Acupuncture
• Heat And Cold Therapy
• Exercise And Stretching
• Other Non-Pharmacological Treatments
• 6.3. Global Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Muscle Pain
• Chronic Muscle Pain
• 6.4. Global Muscle Pain Treatment Market, Segmentation By Cause Of Muscle Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Overuse And Strain
• Injury Or Trauma
• Inflammatory Conditions
• Neurological Conditions
• Infections
• Other Cause Of Muscle Pain
• 6.5. Global Muscle Pain Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Clinic
• Other Applications
• 6.6. Global Muscle Pain Treatment Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• Acetaminophen
• 6.7. Global Muscle Pain Treatment Market, Sub-Segmentation Of Muscle Relaxants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Centrally Acting Muscle Relaxants
• Peripherally Acting Muscle Relaxants
• 6.8. Global Muscle Pain Treatment Market, Sub-Segmentation Of Topical Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Creams & Ointments
• Gels & Sprays
• Patches
• 6.9. Global Muscle Pain Treatment Market, Sub-Segmentation Of Other Pharmacological Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Antidepressants
• Anticonvulsants

7. Muscle Pain Treatment Market Regional And Country Analysis

• 7.1. Global Muscle Pain Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Muscle Pain Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Muscle Pain Treatment Market

• 8.1. Asia-Pacific Muscle Pain Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Muscle Pain Treatment Market

• 9.1. China Muscle Pain Treatment Market Overview
• 9.2. China Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Muscle Pain Treatment Market

• 10.1. India Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Muscle Pain Treatment Market

• 11.1. Japan Muscle Pain Treatment Market Overview
• 11.2. Japan Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Muscle Pain Treatment Market

• 12.1. Australia Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Muscle Pain Treatment Market

• 13.1. Indonesia Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Muscle Pain Treatment Market

• 14.1. South Korea Muscle Pain Treatment Market Overview
• 14.2. South Korea Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Muscle Pain Treatment Market

• 15.1. Western Europe Muscle Pain Treatment Market Overview
• 15.2. Western Europe Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Muscle Pain Treatment Market

• 16.1. UK Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Muscle Pain Treatment Market

• 17.1. Germany Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Muscle Pain Treatment Market

• 18.1. France Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Muscle Pain Treatment Market

• 19.1. Italy Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Muscle Pain Treatment Market

• 20.1. Spain Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Muscle Pain Treatment Market

• 21.1. Eastern Europe Muscle Pain Treatment Market Overview
• 21.2. Eastern Europe Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Muscle Pain Treatment Market

• 22.1. Russia Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Muscle Pain Treatment Market

• 23.1. North America Muscle Pain Treatment Market Overview
• 23.2. North America Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Muscle Pain Treatment Market

• 24.1. USA Muscle Pain Treatment Market Overview
• 24.2. USA Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Muscle Pain Treatment Market

• 25.1. Canada Muscle Pain Treatment Market Overview
• 25.2. Canada Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Muscle Pain Treatment Market

• 26.1. South America Muscle Pain Treatment Market Overview
• 26.2. South America Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Muscle Pain Treatment Market

• 27.1. Brazil Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Muscle Pain Treatment Market

• 28.1. Middle East Muscle Pain Treatment Market Overview
• 28.2. Middle East Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Muscle Pain Treatment Market

• 29.1. Africa Muscle Pain Treatment Market Overview
• 29.2. Africa Muscle Pain Treatment Market, Segmentation By Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Muscle Pain Treatment Market, Segmentation By Non-Pharmacological Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Muscle Pain Treatment Market, Segmentation By Type Of Pain, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Muscle Pain Treatment Market Competitive Landscape And Company Profiles

• 30.1. Muscle Pain Treatment Market Competitive Landscape
• 30.2. Muscle Pain Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Muscle Pain Treatment Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi SA
• 31.3. Bristol Myers Squibb Company
• 31.4. AstraZeneca PLC
• 31.5. Novartis International AG
• 31.6. GlaxoSmithKline plc (GSK)
• 31.7. Eli Lilly and Company
• 31.8. Amgen Inc.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Baxter International Inc.
• 31.11. Haleon Plc
• 31.12. Select Medical Holdings Corporation
• 31.13. Purdue Pharma
• 31.14. Endo Pharmaceuticals Inc.
• 31.15. Concentra Inc.

32. Global Muscle Pain Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Muscle Pain Treatment Market

34. Recent Developments In The Muscle Pain Treatment Market

35. Muscle Pain Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Muscle Pain Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Muscle Pain Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Muscle Pain Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer